Simple blood test could revolutionize care for elderly cancer patients
NCT ID NCT02807129
Summary
This study aimed to find a better way to measure frailty in people aged 65 and older who have cancer. Researchers tested if measuring fragments of a protein called elastin in the blood could provide a more objective and faster assessment than current methods. The goal was to help doctors make more informed decisions about which cancer treatments are safest and most effective for each older patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damien JOLLY
Reims, 51092, France
Conditions
Explore the condition pages connected to this study.